BriaCell Therapeutics Corp. (NASDAQ:BCTX – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 449,200 shares, a decline of 72.8% from the September 15th total of 1,650,000 shares. Currently, 1.6% of the shares of the stock are sold short. Based on an average trading volume of 4,780,000 shares, the short-interest ratio is currently 0.1 days.
Wall Street Analyst Weigh In
Separately, HC Wainwright reiterated a “buy” rating and set a $15.00 price objective on shares of BriaCell Therapeutics in a research report on Thursday, October 3rd.
Check Out Our Latest Stock Report on BriaCell Therapeutics
BriaCell Therapeutics Stock Performance
Hedge Funds Weigh In On BriaCell Therapeutics
An institutional investor recently raised its position in BriaCell Therapeutics stock. K.J. Harrison & Partners Inc raised its holdings in BriaCell Therapeutics Corp. (NASDAQ:BCTX – Free Report) by 7.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 87,044 shares of the company’s stock after purchasing an additional 6,329 shares during the quarter. K.J. Harrison & Partners Inc owned 0.54% of BriaCell Therapeutics worth $249,000 as of its most recent SEC filing. 15.42% of the stock is owned by hedge funds and other institutional investors.
About BriaCell Therapeutics
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer.
Recommended Stories
- Five stocks we like better than BriaCell Therapeutics
- Top Stocks Investing in 5G Technology
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- Overbought Stocks Explained: Should You Trade Them?
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.